Loading clinical trials...
Loading clinical trials...
Measurement of Plasma and Intracellular Concentrations of Raltegravir in Patients Infected With Human Immunodeficiency Virus
Conditions
Interventions
Raltegravir
Locations
1
United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
October 1, 2010
Primary Completion Date
April 30, 2011
Completion Date
June 30, 2011
Last Updated
August 21, 2017
NCT07071623
NCT04929028
NCT01875588
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
University of Nebraska
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions